XML 61 R49.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
RELATED PARTY TRANSACTIONS (Details)
1 Months Ended 3 Months Ended
Feb. 20, 2023
USD ($)
Nov. 23, 2022
$ / shares
shares
May 31, 2023
USD ($)
Oct. 31, 2022
USD ($)
Sep. 30, 2022
USD ($)
Installment
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Nov. 30, 2022
Sep. 09, 2022
USD ($)
Mar. 31, 2022
shares
Related Party Transaction [Abstract]                    
Monthly installment fees amount $ 400,000                  
Notice period for first termination of contract           120 days        
Research and development expense           $ 1,458,000 $ 1,674,000      
License agreement automatic renewal term           5 years        
Percentage of sublicense fees paid before license expiration date 20.00%                  
Exacis Option Agreement [Abstract]                    
Payment of option fee       $ 250,000            
NoveCite, INC. [Member]                    
Related Party Transaction [Abstract]                    
Percentage of non-controlling interest               25.00%    
Minimum [Member]                    
Related Party Transaction [Abstract]                    
Sublicense fees $ 6,000,000                  
Dr. Fiore [Member]                    
Related Party Transaction [Abstract]                    
Monthly installment fees amount     $ 20,000              
Notice period for first termination of contract           15 days        
Factor Bioscience Inc. [Member]                    
Related Party Transaction [Abstract]                    
Notice period for superseding termination provisions           30 days        
Master services agreement, initial fees payable         $ 5,000,000          
Number of monthly installments for fees payable | Installment         12          
Monthly installment fees amount         $ 400,000          
Monthly master services agreement fees payable initial 12-month         5,000,000          
Initial license fees obligation         3,500,000          
Deposit paid to be applied to last month of first work order                 $ 400,000  
Notice period for first termination of contract           120 days        
Agreed waive payment         3,500,000          
Research and development expense         $ 3,500,000          
Remaining unamortized license fee obligation           $ 1,200,000        
PIPE Investor [Member]                    
Q4-22 PIPE [Abstract]                    
Private placement (in shares) | shares   2,185,000                
Unit price (in dollars per share) | $ / shares   $ 3.53                
PIPE Investor [Member] | Common Warrants [Member]                    
Q4-22 PIPE [Abstract]                    
Private placement (in shares) | shares                   343,000
Number of common stock (in shares) | shares   1                
PIPE Investor [Member] | Pre-funded Warrants [Member]                    
Q4-22 PIPE [Abstract]                    
Number of common stock (in shares) | shares   2